DNA/RNA Sample Extraction and Isolation Global Market Report 2024

The DNA/RNA sample extraction and isolation market size has grown strongly in recent years. It will grow from $2.33 billion in 2023 to $2.52 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth observed during the historic period can be attributed to various factors, including advancements in genomics research, an increasing demand for personalized medicine, a rising prevalence of genetic disorders, growing investments in life sciences research, and technological advancements in sample extraction techniques.

The DNA/RNA sample extraction and isolation market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth in the forecast period can be attributed to several factors, including the expanding applications of genomics in diagnostics and drug development, the increasing adoption of precision medicine, a growing awareness and focus on genetic testing, continuous developments in sample extraction technologies, and increasing collaborations and partnerships in the biotechnology sector. Major trends expected in the forecast period include technological advancements in extraction and isolation techniques, the adoption of automation and high-throughput techniques, the emergence of new players and collaborations in the market, a shift towards point-of-care testing and decentralized diagnostics, as well as rising investments in healthcare infrastructure and research and development (R&D).

The escalating incidence of infectious diseases is poised to drive the expansion of the DNA/RNA sample extraction and isolation market. Infectious diseases, caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites, necessitate accurate and sensitive detection methods for effective diagnosis and treatment. DNA/RNA extraction plays a crucial role in PCR-based diagnostic tests, enabling the identification of genetic material from pathogens with precision and sensitivity in patient samples. For instance, data from UNAIDS in July 2023 reveals a global HIV population increase to 39 million in 2022, alongside approximately 1.3 million new HIV infections reported the same year. Similarly, statistics from the Centers for Disease Control and Prevention in March 2023 indicate a rise in tuberculosis cases in the United States, underscoring the pressing need for advanced DNA/RNA sample extraction and isolation methods.

Prominent players in the DNA/RNA sample extraction and isolation market are embracing innovative technologies, including automated sample preparation and analysis solutions, to enhance their market standing. Automated solutions streamline sample processing and analysis steps, facilitating efficient and reproducible workflows. For example, Qiagen N.V. introduced the TissueLyser III and RNeasy PowerMax Soil Pro Kit in November 2023, aimed at improving sample processing and RNA isolation efficiency. The TissueLyser III offers high-throughput capabilities for disrupting various biological samples containing nucleic acids, catering to diverse research needs. On the other hand, the RNeasy PowerMax Soil Pro Kit addresses challenges in isolating high-purity RNA from complex soil samples, employing advanced inhibitor removal technology to ensure accurate analysis results. These innovative solutions exemplify the commitment of market leaders to delivering cutting-edge products tailored to meet evolving research demands in infectious disease diagnostics and research.

In June 2023, Merck & Co. Inc., a leading US-based pharmaceutical company, completed the acquisition of Prometheus Biosciences Inc. for $10.8 billion. This strategic move aligns with Merck's focus on advancing research and development within the field of immunology. The acquisition enables Merck to further its commitment to innovation, particularly in the development of DNA and RNA extraction and isolation technologies for therapeutic and diagnostic applications. Prometheus Biosciences Inc., a biotechnology company based in the US, specializes in providing products for DNA sample extraction and isolation, enhancing Merck's capabilities in this critical area of biotechnology.

Major companies operating in the dna/rna sample extraction and isolation market report are F Hoffmann-La Roche AG, Thermofisher Scientific Inc., Danaher Corporation, MilliporeSigma, Agilent Technologies, Illumina Inc., PerkinElmer Inc., Sigma-Aldrich, bioMérieux SA, Bio-Rad Laboratories Inc., Qiagen N.V., Eppendorf AG, Macherey-Nagel Gmbh & Co. KG, Tecan Group, Promega Corporation, Abnova Corporation, Abcam Plc., Takara Bio Inc., New England Biolabs, Omega Bio-tek Inc., Zymo Research, PCR Biosystems, Biotium Inc., Beckman Coulter, Norgen Biotek Inc.

North America was the largest region in the DNA/RNA sample extraction and isolation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna/rna sample extraction and isolation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dna/rna sample extraction and isolation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

DNA or RNA sample extraction and isolation involve processes to obtain and purify genetic material from biological samples, essential for various research applications such as genomics, transcriptomics, and molecular biology studies.

The main product types in DNA/RNA sample extraction and isolation are consumables and instruments. Consumables include materials and reagents used during the extraction process, with kits and reagents providing the necessary chemicals and materials for extracting DNA and RNA from samples. These are categorized by technology into consumable-based technology and instrument-based technology. Applications encompass polymerase chain reaction (PCR), next-generation sequencing (NGS), cloning, microarray, blotting techniques, and others. End users include clinical diagnostic and forensic laboratories, research academics and institutions, pharmaceutical and biotechnology companies, contract research organizations (CRO), and others.

The DNA/RNA sample extraction and isolation research report is one of a series of new reports that provides DNA/RNA sample extraction and isolation market statistics, including the DNA/RNA sample extraction and isolation industry's global market size, regional shares, competitors with an DNA/RNA sample extraction and isolation market share, detailed DNA/RNA sample extraction and isolation market segments, market trends and opportunities, and any further data you may need to thrive in the DNA/RNA sample extraction and isolation industry. This DNA/RNA sample extraction and isolation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The DNA and RNA sample extraction and isolation market includes revenues earned by entities by high or low volume extraction solutions, buffy coat samples and related products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The DNA and RNA sample extraction and isolation market consists of sales of consumables such as kits and reagents, instruments, and laboratory tools used to extract or isolate DNA and or RNA molecules from various biological samples. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.